Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label, Single-Arm Trial to Assess the Shedding, Immunogenicity, and Safety of FluMist Administered to Healthy Individuals 5-49 Years of Age

NCT00192140 is registered in ClinicalTrials.gov with MedImmune LLC as lead sponsor.

NCT NCT00192140
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00192140 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label, Single-Arm Trial to Assess the Shedding, Immunogenicity, and Safety of FluMist Administered to Healthy Individuals 5-49 Years of Age
Lead sponsor
MedImmune LLC
Phase
Phase 4
Overall status
Completed
Start date
June 30, 2004
Completion date
January 31, 2005
Enrollment
345
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

influenza